316 related articles for article (PubMed ID: 28749468)
1. WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.
Janczar S; Nautiyal J; Xiao Y; Curry E; Sun M; Zanini E; Paige AJ; Gabra H
Cell Death Dis; 2017 Jul; 8(7):e2955. PubMed ID: 28749468
[TBL] [Abstract][Full Text] [Related]
2. WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells.
Zhao Y; Wang W; Pan W; Yu Y; Huang W; Gao J; Zhang Y; Zhang S
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300063
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of WWOX protein in epithelial ovarian cancer: a clinicopathologic and immunohistochemical study.
Lan C; Chenggang W; Yulan B; Xiaohui D; Junhui Z; Xiao W
Int J Gynecol Pathol; 2012 Mar; 31(2):125-32. PubMed ID: 22317867
[TBL] [Abstract][Full Text] [Related]
4. [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer].
Yan HC; Xue JQ; Lu XY; Wan MR; Feng X; Liu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):361-5. PubMed ID: 18953870
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.
Chiang YC; Lin HW; Chang CF; Chang MC; Fu CF; Chen TC; Hsieh SF; Chen CA; Cheng WF
Oncotarget; 2015 Nov; 6(37):39740-55. PubMed ID: 26452028
[TBL] [Abstract][Full Text] [Related]
7. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
[TBL] [Abstract][Full Text] [Related]
8. WWOX regulates the Elf5/Snail1 pathway to affect epithelial-mesenchymal transition of ovarian carcinoma cells in vitro.
Xu Y; Yan YC; Hu YK; Fang LS; Li Q; Xu J; Yan HC
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1041-1053. PubMed ID: 32096174
[TBL] [Abstract][Full Text] [Related]
9. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
[TBL] [Abstract][Full Text] [Related]
10. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
[TBL] [Abstract][Full Text] [Related]
11. [Suppression of WWOX gene by RNA interference reverses platinum resistance acquired in SKOV3/SB cells].
Liu YY; Li L; Li DR; Zhang W; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):854-8. PubMed ID: 19087571
[TBL] [Abstract][Full Text] [Related]
12. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
13. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
14. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.
Chiang YC; Chang MC; Chen PJ; Wu MM; Hsieh CY; Cheng WF; Chen CA
Endocr Relat Cancer; 2013 Apr; 20(2):213-27. PubMed ID: 23329649
[TBL] [Abstract][Full Text] [Related]
16. WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use.
Chen Y; Tan X; Ding Y; Mai B; Huang X; Hu G; Luo X
Biomed Res Int; 2016; 2016():6594039. PubMed ID: 27190995
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
[TBL] [Abstract][Full Text] [Related]
18. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.
Zheng QW; Zhou YL; You QJ; Shou F; Pang QF; Chen JL
Cancer Gene Ther; 2016 Dec; 23(12):433-438. PubMed ID: 27834355
[TBL] [Abstract][Full Text] [Related]
19. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.
Wu YH; Chang TH; Huang YF; Chen CC; Chou CY
Oncotarget; 2015 Sep; 6(27):23748-63. PubMed ID: 26087191
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]